€1.53
4.39% today
Brüssel, Feb 28, 05:24 pm CET
ISIN
BE0974340722
Symbol
SEQUA
Sector

Sequana Medical Stock price

€1.60
-0.97 37.70% 1M
+0.62 62.76% 6M
-1.47 47.88% YTD
-1.00 38.42% 1Y
-4.73 74.76% 3Y
-4.91 75.46% 5Y
-6.83 81.06% 10Y
Brüssel, Closing price Thu, Feb 27 2025
-0.06 3.33%
ISIN
BE0974340722
Symbol
SEQUA
Sector

Key metrics

Market capitalization €83.60m
Enterprise Value €101.78m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 236.70
P/S ratio (TTM) P/S ratio 194.42
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -48.54%
Revenue (TTM) Revenue €430.00k
EBIT (operating result TTM) EBIT €-23.24m
Free Cash Flow (TTM) Free Cash Flow €-26.51m
EPS (TTM) EPS €-0.91
P/S forward 347.43
EV/Sales forward 422.98
Show more

Is Sequana Medical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Sequana Medical Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Sequana Medical forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a Sequana Medical forecast:

Buy
67%
Hold
33%

Financial data from Sequana Medical

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
0.43 0.43
49% 49%
100%
- Direct Costs 3.69 3.69
29% 29%
858%
-3.25 -3.25
26% 26%
-756%
- Selling and Administrative Expenses 16 16
10% 10%
3,751%
- Research and Development Expense 3.19 3.19
55% 55%
742%
-23 -23
24% 24%
-5,251%
- Depreciation and Amortization 0.66 0.66
23% 23%
153%
EBIT (Operating Income) EBIT -23 -23
24% 24%
-5,404%
Net Profit -27 -27
16% 16%
-6,321%

In millions EUR.

Don't miss a Thing! We will send you all news about Sequana Medical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company focuses on the treatment solutions for the management of liver disease, heart failure, malignant ascites, and other fluid imbalance disorders. It offers alfapump, an implantable, programmable, wirelessly-charged, battery-powered system that manages refractory ascites and malignant ascites. The company was founded by Noel L. Johnson in 2006 and is headquartered in Ghent, Belgium.

Head office Belgium
CEO Ian Crosbie
Founded 2018
Website www.sequanamedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today